ID: ALA1916341

Max Phase: Preclinical

Molecular Formula: C22H42N3O17P3S

Molecular Weight: 745.57

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=C(CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@@H]21)NCCCCCCOP(=O)(O)O[C@@H]1[C@H](O)[C@H](O)[C@@H](OP(=O)(O)O)[C@H](OP(=O)(O)O)[C@H]1O

Standard InChI:  InChI=1S/C22H42N3O17P3S/c26-14(8-4-3-7-13-15-12(11-46-13)24-22(30)25-15)23-9-5-1-2-6-10-39-45(37,38)42-19-16(27)17(28)20(40-43(31,32)33)21(18(19)29)41-44(34,35)36/h12-13,15-21,27-29H,1-11H2,(H,23,26)(H,37,38)(H2,24,25,30)(H2,31,32,33)(H2,34,35,36)/t12-,13-,15-,16+,17-,18-,19+,20+,21+/m0/s1

Standard InChI Key:  BQVUUMBKNRDWRD-TUDGDOFTSA-N

Associated Targets(non-human)

Cyth3 Cytohesin-3 (5 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Plcd1 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-1 (5 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 745.57Molecular Weight (Monoisotopic): 745.1448AlogP: -1.06#Rotatable Bonds: 19
Polar Surface Area: 320.20Molecular Species: ACIDHBA: 13HBD: 11
#RO5 Violations: 3HBA (Lipinski): 20HBD (Lipinski): 11#RO5 Violations (Lipinski): 3
CX Acidic pKa: 0.63CX Basic pKa: 1.96CX LogP: -2.74CX LogD: -12.57
Aromatic Rings: 0Heavy Atoms: 46QED Weighted: 0.04Np Likeness Score: 0.43

References

1. Anraku K, Inoue T, Sugimoto K, Kudo K, Okamoto Y, Morii T, Mori Y, Otsuka M..  (2011)  Design and synthesis of biotinylated inositol 1,3,4,5-tetrakisphosphate targeting Grp1 pleckstrin homology domain.,  19  (22): [PMID:21996606] [10.1016/j.bmc.2011.09.035]

Source